XML 22 R30.htm IDEA: XBRL DOCUMENT v3.19.3
Segment Information (Tables)
 3 Months Ended
Sep. 30, 2019
Segment Reporting, Revenue Reconciling Item [Line Items]  
Revenue from External Customers by Geographic Areas [Table Text Block]
The following table presents revenue by geographic area:
 
Three Months Ended September 30,
(in millions)
2019
 
2018
United States
$
36,310

 
$
34,245

International
1,035

 
972

  Total segment revenue
37,345

 
35,217

Corporate (1)
(4
)
 
(4
)
Total revenue
$
37,341

 
$
35,213

(1)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue by Reportable Segment  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
The following table presents revenue for each reportable segment, disaggregated revenue within our two reportable segments and Corporate:
 
Three Months Ended September 30,
(in millions)
2019
 
2018
Pharmaceutical Distribution and Specialty Solutions (1)
$
33,212

 
$
31,209

Nuclear and Precision Health Solutions
216

 
207

Pharmaceutical segment revenue
33,428

 
31,416

Medical distribution and products (2)
3,446

 
3,380

Cardinal Health at-Home Solutions
471

 
421

Medical segment revenue
3,917

 
3,801

  Total segment revenue
37,345

 
35,217

Corporate (3)
(4
)
 
(4
)
Total revenue
$
37,341

 
$
35,213

(1)
Products and services offered by our Specialty Solutions division are referred to as “specialty pharmaceutical products and services".
(2)
Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.
(3)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following table presents segment profit by reportable segment and Corporate:
 
Three Months Ended September 30,
(in millions)
2019
 
2018
Pharmaceutical
$
398

 
$
409

Medical
170

 
135

Total segment profit
568

 
544

Corporate
(5,832
)
 
272

Total operating earnings/(loss)
$
(5,264
)
 
$
816
Assets by Reportable Segment
The following table presents total assets for each reportable segment and Corporate at:
(in millions)
September 30,
2019
 
June 30,
2019
Pharmaceutical
$
21,755

 
$
22,446

Medical
15,462

 
15,284

Corporate
1,962

 
3,233

Total assets
$
39,179

 
$
40,963